Anika Therapeutics, Inc.
ANIK
Revenue
-1.29M
▼-40.04M▼-103.33%
3 Months ChangeAssets
202.74M
▼-28.67M▼-12.39%
3 Months ChangeLiabilities
48.75M
▼-2.79M▼-5.41%
3 Months ChangeFree Cash Flow
-1.93M
▲3.07M▲61.37%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 8-K
ID: 0001171843-24-005923
2024-10-31
Form 8-K
ID: 0001171843-24-005922
2024-08-08
Form 10-Q
ID: 0001171843-24-004615
2024-08-08
Form 8-K
ID: 0001171843-24-004607
2024-07-11
Form 8-K
ID: 0001171843-24-003900
2024-05-28
Form 8-K
ID: 0001171843-24-003136
2024-05-08
Form 10-Q
ID: 0001171843-24-002682
2024-05-08
Form 8-K
ID: 0001171843-24-002673
2024-05-08
Form 8-K
ID: 0001171843-24-002672
2024-03-13
Form 8-K
ID: 0001171843-24-001322